David Meeker

David Meeker

Chair of the BoardatRhythm Pharmaceuticals· In proxies 2021–2025

Pay in FY2025+20% from the year before · Rhythm Pharmaceuticals stock +91.2% the same year

David Meeker was paid $17.5M in FY2025 (Dec), up 20%. Rhythm Pharmaceuticals stock rose 91.2% that year.

Pay$100 in the stock at the end of FY20 → $360
Pay is from the Summary Compensation Table of each Rhythm Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Trevi TherapeuticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  2. Rhythm PharmaceuticalsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role +217%
  3. Pharvaris GmbHPublic company
    • Director? – PresentNo stock prices for these years
  4. Trevi Therapeutics, IncPublic company
    • Director? – PresentNo stock prices for these years
  5. MyoKardia, Inc.Public company · 3 yr
    • Director2017 – 2020 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?